药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Glucosamine
9-(N-methyl-L-isoleucine)-cyclosporin A
The risk or severity of adverse effects can be increased when Ponatinib is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.
Glucosamine
Hypericin
The risk or severity of adverse effects can be increased when Ponatinib is combined with Hypericin.
Glucosamine
Acteoside
The risk or severity of adverse effects can be increased when Ponatinib is combined with Acteoside.
Glucosamine
Deoxyspergualin
The risk or severity of adverse effects can be increased when Ponatinib is combined with Deoxyspergualin.
Glucosamine
Doxifluridine
The risk or severity of adverse effects can be increased when Ponatinib is combined with Doxifluridine.
Glucosamine
Trofosfamide
The risk or severity of adverse effects can be increased when Ponatinib is combined with Trofosfamide.
Glucosamine
Cepeginterferon alfa-2B
The risk or severity of adverse effects can be increased when Ponatinib is combined with Cepeginterferon alfa-2B.
Glucosamine
Gusperimus
The risk or severity of adverse effects can be increased when Ponatinib is combined with Gusperimus.
Glucosamine
Mizoribine
The risk or severity of adverse effects can be increased when Ponatinib is combined with Mizoribine.
Glucosamine
Triptolide
The risk or severity of adverse effects can be increased when Ponatinib is combined with Triptolide.
Glucosamine
Ocrelizumab
The risk or severity of adverse effects can be increased when Ponatinib is combined with Ocrelizumab.
Glucosamine
Guselkumab
The risk or severity of adverse effects can be increased when Ponatinib is combined with Guselkumab.
Glucosamine
Baricitinib
The risk or severity of adverse effects can be increased when Ponatinib is combined with Baricitinib.
Glucosamine
Sirukumab
The risk or severity of adverse effects can be increased when Ponatinib is combined with Sirukumab.
Glucosamine
Brodalumab
The risk or severity of adverse effects can be increased when Ponatinib is combined with Brodalumab.
Glucosamine
Peficitinib
The risk or severity of adverse effects can be increased when Ponatinib is combined with Peficitinib.
Glucosamine
Voclosporin
The risk or severity of adverse effects can be increased when Ponatinib is combined with Voclosporin.
Glucosamine
Pirarubicin
The risk or severity of adverse effects can be increased when Ponatinib is combined with Pirarubicin.
Glucosamine
Ravulizumab
The risk or severity of adverse effects can be increased when Ponatinib is combined with Ravulizumab.
Glucosamine
Ixekizumab
The risk or severity of adverse effects can be increased when Ponatinib is combined with Ixekizumab.